BRPI0916001A2 - dispositivo para medição e gerenciamento de analitos e métodos associados - Google Patents

dispositivo para medição e gerenciamento de analitos e métodos associados

Info

Publication number
BRPI0916001A2
BRPI0916001A2 BRPI0916001A BRPI0916001A BRPI0916001A2 BR PI0916001 A2 BRPI0916001 A2 BR PI0916001A2 BR PI0916001 A BRPI0916001 A BR PI0916001A BR PI0916001 A BRPI0916001 A BR PI0916001A BR PI0916001 A2 BRPI0916001 A2 BR PI0916001A2
Authority
BR
Brazil
Prior art keywords
therapeutic agent
user
wireless module
delivery device
associated methods
Prior art date
Application number
BRPI0916001A
Other languages
English (en)
Inventor
Horwitz David
Price David
Savage Donna
Krulevitch Peter
Shartle Robert
Sieh Zara
Original Assignee
Lifescan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifescan Inc filed Critical Lifescan Inc
Publication of BRPI0916001A2 publication Critical patent/BRPI0916001A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems

Abstract

"dispositivo para medição e gerenciamento de analitos e métodos associados". a presente invenção fornece várias modalidades de um sistema para gerenciamento de diabetes. um sistema exemplificador pode incluir um dispositivo para medição de analito e um dispositivo para aplicação de agente terapêutico. o dispositivo de medição inclui uma unidade de medição, uma tela, e um primeiro módulo sem fio. o dispositivo para aplicação de agente terapêutico tem um alojamento do dispositivo para aplicação, um mecanismo de aplicação disposto no alojamento que libera uma dosagem do agente ao usuário mediante acionamento pelo usuário ou pelo provedor de cuidados com a saúde e um segundo módulo sem fio. o segundo módulo sem fio transmite automaticamente, sem solicitação de um usuário ou sem qualquer entrada ativa ou ação por parte do usuário, um sinal ao primeiro módulo sem fio indicativo de: (a) tipo de agente terapêutico aplicado; e (b) quantidade do agente terapêutico aplicada ao usuário; ou (c) tipo de dispositivo de agente terapêutico a partir do qual o agente terapêutico foi administrado. também são descritos dispositivos e métodos para o gerenciamento de diabetes.
BRPI0916001A 2008-07-18 2009-07-17 dispositivo para medição e gerenciamento de analitos e métodos associados BRPI0916001A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8210608P 2008-07-18 2008-07-18
PCT/US2009/050971 WO2010009382A2 (en) 2008-07-18 2009-07-17 Analyte measurement and management device and associated methods

Publications (1)

Publication Number Publication Date
BRPI0916001A2 true BRPI0916001A2 (pt) 2019-07-09

Family

ID=41530902

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0916001A BRPI0916001A2 (pt) 2008-07-18 2009-07-17 dispositivo para medição e gerenciamento de analitos e métodos associados

Country Status (7)

Country Link
US (1) US20100016700A1 (pt)
EP (1) EP2315549A2 (pt)
JP (1) JP2012507309A (pt)
CN (1) CN102548467A (pt)
BR (1) BRPI0916001A2 (pt)
CA (1) CA2731031A1 (pt)
WO (1) WO2010009382A2 (pt)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
AU2002315180A1 (en) 2001-06-12 2002-12-23 Pelikan Technologies, Inc. Electric lancet actuator
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
CA2448902C (en) 2001-06-12 2010-09-07 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
US7041068B2 (en) * 2001-06-12 2006-05-09 Pelikan Technologies, Inc. Sampling module device and method
WO2002100254A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7175642B2 (en) 2002-04-19 2007-02-13 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US8372016B2 (en) 2002-04-19 2013-02-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling and analyte sensing
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US8262614B2 (en) 2003-05-30 2012-09-11 Pelikan Technologies, Inc. Method and apparatus for fluid injection
US7850621B2 (en) 2003-06-06 2010-12-14 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US8282576B2 (en) 2003-09-29 2012-10-09 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
WO2005037095A1 (en) 2003-10-14 2005-04-28 Pelikan Technologies, Inc. Method and apparatus for a variable user interface
US8668656B2 (en) 2003-12-31 2014-03-11 Sanofi-Aventis Deutschland Gmbh Method and apparatus for improving fluidic flow and sample capture
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
WO2005120365A1 (en) 2004-06-03 2005-12-22 Pelikan Technologies, Inc. Method and apparatus for a fluid sampling device
EP1835848A4 (en) * 2004-12-30 2009-07-29 Pelikan Technologies Inc METHOD AND DEVICE FOR ANALYTE MEASUREMENT TEST TIME
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
US10624577B2 (en) 2008-04-04 2020-04-21 Hygieia, Inc. Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus
US9220456B2 (en) 2008-04-04 2015-12-29 Hygieia, Inc. Systems, methods and devices for achieving glycemic balance
CN102016906B (zh) 2008-04-04 2013-07-17 海吉雅有限公司 用于优化患者的胰岛素剂量方案的系统
WO2009126900A1 (en) 2008-04-11 2009-10-15 Pelikan Technologies, Inc. Method and apparatus for analyte detecting device
US20100095229A1 (en) * 2008-09-18 2010-04-15 Abbott Diabetes Care, Inc. Graphical user interface for glucose monitoring system
WO2010056718A2 (en) 2008-11-11 2010-05-20 Hygieia, Inc. Apparatus and system for diabetes management
CA2747332C (en) 2008-12-23 2015-01-27 F. Hoffmann-La Roche Ag Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
US20120011125A1 (en) 2008-12-23 2012-01-12 Roche Diagnostics Operations, Inc. Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
US9918635B2 (en) 2008-12-23 2018-03-20 Roche Diabetes Care, Inc. Systems and methods for optimizing insulin dosage
US8849458B2 (en) 2008-12-23 2014-09-30 Roche Diagnostics Operations, Inc. Collection device with selective display of test results, method and computer program product thereof
US9117015B2 (en) 2008-12-23 2015-08-25 Roche Diagnostics Operations, Inc. Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
US10456036B2 (en) 2008-12-23 2019-10-29 Roche Diabetes Care, Inc. Structured tailoring
US10437962B2 (en) 2008-12-23 2019-10-08 Roche Diabetes Care Inc Status reporting of a structured collection procedure
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
JP2012532323A (ja) * 2009-06-30 2012-12-13 ライフスキャン・インコーポレイテッド 分析物試験方法及びシステム
EP2449493A2 (en) * 2009-06-30 2012-05-09 Lifescan Scotland Limited Systems for diabetes management and methods
RU2553387C2 (ru) * 2009-06-30 2015-06-10 Лайфскен, Инк. Способы определения концентрации аналита и устройство для расчета терапевтической дозы базального инсулина
RU2559931C2 (ru) * 2009-09-29 2015-08-20 Лайфскэн Скотлэнд Лимитед Способ тестирования аналита и устройство для контроля для пациентов, страдающих сахарным диабетом
US9563743B2 (en) * 2010-02-25 2017-02-07 Lifescan Scotland Limited Analyte testing method and system with high and low blood glucose trends notification
AU2010346624A1 (en) * 2010-02-25 2012-09-06 Lifescan Scotland Limited Analyte testing method and system with safety warnings for insulin dosing
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8532933B2 (en) 2010-06-18 2013-09-10 Roche Diagnostics Operations, Inc. Insulin optimization systems and testing methods with adjusted exit criterion accounting for system noise associated with biomarkers
JP2012032206A (ja) * 2010-07-29 2012-02-16 National Institute Of Advanced Industrial & Technology 電気化学分析装置
US8206340B2 (en) * 2010-08-18 2012-06-26 Thuban, Inc. Integrated glucose monitor and insulin injection pen with automatic emergency notification
US8868794B2 (en) 2010-12-27 2014-10-21 Medtronic, Inc. Application limitations for a medical communication module and host device
US20120173151A1 (en) 2010-12-29 2012-07-05 Roche Diagnostics Operations, Inc. Methods of assessing diabetes treatment protocols based on protocol complexity levels and patient proficiency levels
CH704393B1 (de) * 2011-01-28 2020-04-30 D Van Gelder Max Einrichtung zur Kontrolle von diabetesrelevanten Daten.
JP6175049B2 (ja) * 2011-03-30 2017-08-02 ノボ・ノルデイスク・エー／エス 患者の長期薬剤投与計画の最適化システム
EP2705453B1 (en) 2011-05-06 2018-12-19 Novo Nordisk A/S System for optimizing a drug dosage regimen over time
US8755938B2 (en) 2011-05-13 2014-06-17 Roche Diagnostics Operations, Inc. Systems and methods for handling unacceptable values in structured collection protocols
US10448869B2 (en) 2011-05-13 2019-10-22 Roche Diabetes Care, Inc. User-defined structured testing for use in diabetes care
US8766803B2 (en) 2011-05-13 2014-07-01 Roche Diagnostics Operations, Inc. Dynamic data collection
US20130085349A1 (en) 2011-06-21 2013-04-04 Yofimeter, Llc Analyte testing devices
EP2798546B1 (en) * 2011-09-13 2020-12-23 Novo Nordisk A/S Adaptive system for optimizing a drug dosage regimen over time
WO2013053695A1 (en) 2011-10-11 2013-04-18 Novo Nordisk A/S Dual purpose advisory device
US8886619B2 (en) 2011-12-29 2014-11-11 Roche Diagnostics Operations, Inc. Structured test adherence management for manual data entry systems
US9259190B2 (en) 2011-12-29 2016-02-16 Roche Diabetes Care, Inc. Reminder management for manual entry diabetes application
CN103190914A (zh) * 2012-01-04 2013-07-10 胡吉 一种用于血糖仪数据无线传输的装置
WO2014008288A1 (en) * 2012-07-03 2014-01-09 Edwards Lifesciences Corporation Therapeutic agent delivery based on stored patient analyte values
US10318915B2 (en) 2012-09-26 2019-06-11 Thuban, Inc. Healthcare system for recording and monitoring transactions of system participants
US9357961B2 (en) 2013-02-22 2016-06-07 Thuban, Inc. Device for enabling patient self testing and treatment self- administration and system using the device for managing the patient's health care
US20140275903A1 (en) * 2013-03-14 2014-09-18 Lifescan Scotland Limited System and method for quick-access physiological measurement history
US9377485B2 (en) 2013-03-15 2016-06-28 Fluke Corporation Handheld measurement system with selectable options
US10453566B2 (en) 2013-04-26 2019-10-22 Roche Diabetes Care, Inc. Method for reconciling medical data captured on one device with a structured test administered on another device
US20140379360A1 (en) * 2013-06-25 2014-12-25 Lifescan, Inc. Low glucose treatment for people with diabetes
PT107092B (pt) * 2013-07-31 2015-11-04 Têxteis Penedo S A Material compósito, processo de obtenção e suas aplicações
EP3399453B1 (en) * 2013-10-25 2020-12-16 Ascensia Diabetes Care Holdings AG Hardware key system for device protection
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
GB201407896D0 (en) * 2014-05-05 2014-06-18 Joanneum Res Forschungsgmbh Insulin dosage proposal system
DE202015010002U1 (de) 2014-05-21 2022-12-12 Abbott Diabetes Care, Inc. Management mehrerer Vorrichtungen innerhalb einer Analytüberwachungsumgebung
US11035818B2 (en) * 2014-08-15 2021-06-15 Roche Diabetes Care, Inc. Blood glucose meter with low cost user interface having programmed graphic indicators
WO2016040345A1 (en) * 2014-09-10 2016-03-17 Bayer Healthcare Llc Smart logging for management of health-related issues
US10971260B2 (en) 2014-09-14 2021-04-06 Becton, Dickinson And Company System and method for capturing dose information
US10704944B2 (en) 2014-09-14 2020-07-07 Becton, Dickinson And Company System and method for capturing dose information
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
US9892234B2 (en) 2014-10-27 2018-02-13 Aseko, Inc. Subcutaneous outpatient management
AU2016308953B2 (en) 2015-08-20 2020-09-10 Aseko, Inc. Diabetes management therapy advisor
JP6987042B2 (ja) * 2015-08-26 2021-12-22 レスメッド センサー テクノロジーズ リミテッド 慢性疾患の監視および管理のためのシステムおよび方法
WO2018064222A1 (en) * 2016-09-27 2018-04-05 Bigfoot Biomedical, Inc. Medicine injection and disease management systems, devices, and methods
CN109922716A (zh) 2016-12-12 2019-06-21 比格福特生物医药公司 药物输送设备的警报和警惕以及相关的系统和方法
CN107158522A (zh) * 2017-05-31 2017-09-15 北京糖护科技有限公司 一种胰岛素注射器智能化装置
USD839294S1 (en) 2017-06-16 2019-01-29 Bigfoot Biomedical, Inc. Display screen with graphical user interface for closed-loop medication delivery
JP7235745B2 (ja) * 2017-10-31 2023-03-08 ノボ・ノルデイスク・エー／エス 無線通信を使用する医療装置の制御
EP3826700A1 (en) * 2018-07-26 2021-06-02 Sanofi Method of adjusting medication doses
WO2021170641A1 (en) 2020-02-25 2021-09-02 Novo Nordisk A/S Add-on dose logging device with dose guidance functionality
US20230256166A1 (en) * 2022-02-16 2023-08-17 Modular Medical, Inc. Portable infusion pump with remote activator

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US654672A (en) * 1899-09-05 1900-07-31 Harry T Rich Bicycle-lock.
US4731726A (en) * 1986-05-19 1988-03-15 Healthware Corporation Patient-operated glucose monitor and diabetes management system
US5307263A (en) * 1992-11-17 1994-04-26 Raya Systems, Inc. Modular microprocessor-based health monitoring system
US5536249A (en) * 1994-03-09 1996-07-16 Visionary Medical Products, Inc. Pen-type injector with a microprocessor and blood characteristic monitor
US5665065A (en) * 1995-05-26 1997-09-09 Minimed Inc. Medication infusion device with blood glucose data input
US6270455B1 (en) * 1997-03-28 2001-08-07 Health Hero Network, Inc. Networked system for interactive communications and remote monitoring of drug delivery
RU2234238C2 (ru) * 1998-11-30 2004-08-20 Ново Нордиск А/С Медицинская система и способ управления системой для применения пациентами для самостоятельного проведения медицинских процедур
US6192891B1 (en) * 1999-04-26 2001-02-27 Becton Dickinson And Company Integrated system including medication delivery pen, blood monitoring device, and lancer
US6804656B1 (en) * 1999-06-23 2004-10-12 Visicu, Inc. System and method for providing continuous, expert network critical care services from a remote location(s)
US7044911B2 (en) * 2001-06-29 2006-05-16 Philometron, Inc. Gateway platform for biological monitoring and delivery of therapeutic compounds
US6544212B2 (en) * 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
CA2427976A1 (en) * 2001-08-20 2003-02-27 Inverness Medical Limited Wireless diabetes management devices and methods for using the same
US20030040821A1 (en) * 2001-08-24 2003-02-27 Christopher Case System and method for portable personal diabetic management
US20030114885A1 (en) * 2001-10-02 2003-06-19 Nova Richard C. System and device for implementing an integrated medical device component package
WO2003047426A1 (en) * 2001-12-03 2003-06-12 Eli Lilly And Company Medication delivery device having communication capability with glucose monitor
US20030212379A1 (en) * 2002-02-26 2003-11-13 Bylund Adam David Systems and methods for remotely controlling medication infusion and analyte monitoring
US6852104B2 (en) * 2002-02-28 2005-02-08 Smiths Medical Md, Inc. Programmable insulin pump
JP2004000555A (ja) * 2002-04-25 2004-01-08 Matsushita Electric Ind Co Ltd 投薬量決定支援装置、注射器および健康管理支援システム
US7278983B2 (en) * 2002-07-24 2007-10-09 Medtronic Minimed, Inc. Physiological monitoring device for controlling a medication infusion device
EP1575656B1 (en) * 2002-10-11 2009-06-17 Becton, Dickinson and Company Insulin delivery system with sensor
US8016798B2 (en) * 2003-02-24 2011-09-13 Integrated Sensing Systems, Inc. Fluid delivery system and sensing unit therefor
WO2004084820A2 (en) * 2003-03-19 2004-10-07 Harry Hebblewhite Method and system for determining insulin dosing schedules and carbohydrate-to-insulin ratios in diabetic patients
US20050038674A1 (en) * 2003-04-15 2005-02-17 Braig James R. System and method for managing a chronic medical condition
CA2520880A1 (en) * 2003-04-18 2004-11-04 Insulet Corporation User interface for infusion pump remote controller and method of using the same
US7591801B2 (en) * 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US20050050330A1 (en) * 2003-08-27 2005-03-03 Leedor Agam Security token
CN1871046B (zh) * 2003-11-06 2010-10-27 生命扫描有限公司 带有事件通知装置的药物配送笔
US8532730B2 (en) * 2006-10-04 2013-09-10 Dexcom, Inc. Analyte sensor
US20050137573A1 (en) * 2003-12-19 2005-06-23 Animas Corporation System, method, and communication hub for controlling external infusion device
WO2005106017A2 (en) * 2004-04-21 2005-11-10 University Of Virginia Patent Foundation Method, system and computer program product for evaluating the accuracy of blood glucose monitoring sensors/devices
CA2858901C (en) * 2004-06-04 2024-01-16 Carolyn Anderson Diabetes care host-client architecture and data management system
WO2006032652A1 (en) * 2004-09-23 2006-03-30 Novo Nordisk A/S Remote commander to be used with a drug delivery device
US20060089540A1 (en) * 2004-10-27 2006-04-27 Alan Meissner Device for diabetes management
US20060173417A1 (en) * 2005-01-10 2006-08-03 Richard Rosen Combination insulin pen and transmission device
WO2007038059A2 (en) * 2005-09-26 2007-04-05 M2 Medical A/S Infusion pump with a drive having a ratchet and pawl combination
EP3064236B1 (en) * 2005-11-08 2020-02-05 Bigfoot Biomedical, Inc. Method and system for manual and autonomous control of an infusion pump
US7981034B2 (en) * 2006-02-28 2011-07-19 Abbott Diabetes Care Inc. Smart messages and alerts for an infusion delivery and management system
US7824333B2 (en) * 2006-03-31 2010-11-02 Lifescan, Inc. Diabetes management methods and systems
US7942844B2 (en) * 2006-04-28 2011-05-17 Medtronic Minimed, Inc. Remote monitoring for networked fluid infusion systems

Also Published As

Publication number Publication date
CA2731031A1 (en) 2010-01-21
US20100016700A1 (en) 2010-01-21
WO2010009382A3 (en) 2012-08-02
JP2012507309A (ja) 2012-03-29
CN102548467A (zh) 2012-07-04
EP2315549A2 (en) 2011-05-04
WO2010009382A2 (en) 2010-01-21

Similar Documents

Publication Publication Date Title
BRPI0916001A2 (pt) dispositivo para medição e gerenciamento de analitos e métodos associados
Kulkarni et al. Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of child-bearing age
Freedberg et al. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study
Heresco-Levy et al. High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia
Apelqvist et al. Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007) Prepared by the International Working Group on the Diabetic Foot
Pyrć et al. SARS-CoV-2 inhibition using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray
Geller et al. Pharmacokinetics and safety of MP-376 (levofloxacin inhalation solution) in cystic fibrosis subjects
ES2522834T3 (es) Método y sistema de ensayo de analitos
BR112012019101A2 (pt) módulo medicamentoso com botão de uso duplo e sistema de fornecimento de medicamento.
Miles et al. A controlled trial of skin-to-skin contact in extremely preterm infants
BR112012020270A2 (pt) sistema e método para administrar medicamentos com base em valores de urina.
BRPI0511611A (pt) configuração de dispositivo médico baseada em reconhecimento de informação de identificação
BRPI0519739A2 (pt) combinaÇço compreendendo um agente fornecendo um sinal, um material de implante e uma droga
Brajon et al. Non‐irritant concentrations and amounts of active ingredient in drug patch tests
BRPI0507175A (pt) sistema e método para dispensa de droga adaptativa
BR112012019549A2 (pt) reservatório para uso em um módulo medicamentoso, módulo medicamentoso que compreende esse reservatório e dispositivo de entrega de fármaco.
RU2013120968A (ru) Служба предупреждающих сообщений
BR112017012448A2 (pt) dispositivo de medição de tempo de repreenchimento capilar, e método para medir tempo de repreenchimento capilar
ATE294608T1 (de) Verabreichungsystem für medikamente
Liew et al. Statins use is associated with poorer glycaemic control in a cohort of hypertensive patients with diabetes and without diabetes
Flynn et al. Pro/con debate: Is etomidate safe in hemodynamically unstable critically ill patients?
González-Rodríguez et al. Health worker exposure risk during inhalation sedation with sevoflurane using the (AnaConDa®) anaesthetic conserving device
Moore et al. Randomized 5‐treatment crossover study to assess the effects of external heat on serum fentanyl concentrations during treatment with transdermal fentanyl systems
BRPI0919268A8 (pt) Aptâmero que se liga ao ngf e medicamento
BR112022005654A2 (pt) Agregação remota de dados para dispositivos de administração de fármacos

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority

Free format text: PERDA DA PRIORIDADE 18/07/2008 US 61/082,106, POR NAO CUMPRIMENTO DE EXIGENCIA RELATIVA A REIVINDICACAO DE PRIORIDADE.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
B350 Update of information on the portal [chapter 15.35 patent gazette]